EN
中文
EN
Who We Are
Newsroom
Innovation
Products
Investor Relations
Careers
Contact Us
Information Disclosure
Home
>
Investor Relations
>
Information Disclosure
H Share
Monthly Return of Equity Issuer on Movements in Securities
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026
VOLUNTARY ANNOUNCEMENT - UPDATE ON mRNA TECHNOLOGY PLATFORM DEVELOPMENT
INSIDE INFORMATION - NMPA OF CHINA GRANTS NDA APPROVAL TO TETANUS VACCINE
VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF NEW DRUG APPLICATION FOR TD5CP ADOLESCENT AND ADULT
NOTICE OF BOARD MEETING
Monthly Return of Equity Issuer on Movements in Securities
VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF THE SUPPLEMENTAL DRUG APPLICATION FOR MENHYCIA
Monthly Return of Equity Issuer on Movements in Securities
VOLUNTARY ANNOUNCEMENT - MCV4 OBTAINS DRUG REGISTRATION CERTIFICATE IN ARGENTINA
1
2
3
4
5
6
53
津公网安备12011602300399
